NIH-funded research R21 grant

Exploring ways to slow down myopia progression using animal models

Official title: Application of an optical defocus model to explore mechanisms underlying myopia and control interventions

Funded at University of California Berkeley · NIH-10952028 · Data updated 2026-11-12

This study is looking at how to slow down myopia, or short-sightedness, by testing different medications in guinea pigs that have similar eyes to humans, to find better ways to help people with this condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2026
Funding year2024
Award (this year)$441,375
NIH project number1R21EY036585-01
Project IDNIH-10952028 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals, particularly children, who are at risk of developing or are currently experiencing myopia.

Less likely to help

Patients with myopia who are not responsive to pharmacological treatments or those with advanced myopia complications may not benefit from this research.

What this research studies

This research investigates the mechanisms behind myopia, or short-sightedness, using a guinea pig model that mimics human eye structure. The study aims to test various pharmacological treatments, including combinations of levodopa and atropine, to see how they can inhibit the progression of myopia. Advanced imaging techniques and biometric measurements will be employed to assess the effectiveness of these treatments and understand their underlying mechanisms. By focusing on these innovative approaches, the research seeks to develop effective interventions for myopia control.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively slow the progression of myopia, potentially reducing the risk of serious eye complications.

How similar studies have gone: Previous research has shown promise in using pharmacological approaches to manage myopia, indicating that this study builds on established concepts while exploring novel combinations.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Wildsoet, Christine Frances — University of California Berkeley
  • Study coordinator: Wildsoet, Christine Frances

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.